Related Experiment Video
Updated: Jun 13, 2026

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging
Published on: April 28, 2021
Targeting the DNA double strand breaks repair for cancer therapy
Francesca Gullotta1, Elisabetta De Marinis, Paolo Ascenzi
1Department of Biology, University Roma Tre, Viale Guglielmo Marconi 446, I-00146 Roma, Italy.
Abstract:
Among several types of DNA lesions, the DNA double strand breaks (DSBs) are one of the most deleterious and harmful. Mammalian cells mount a coordinated response to DSBs with the aim of appropriately repair the DNA damage. Indeed, failure of the DNA damage response (DDR) can lead to the development of cancer-prone genetic diseases. The identification and development of drugs targeting proteins involved in the DDR is even more investigated, as it gives the possibility to specifically target cancer cells. Indeed, the administration of DNA repair inhibitors could be combined with chemo- and radiotherapy, thus improving the eradication of tumor cells. Here, we provide an overview about DSBs damage response, focusing on the role of the DSBs repair mechanisms, of chromatin modifications, and of the cancer susceptibility gene BRCA1 which plays a multifunctional role in controlling genome integrity. Moreover, the most investigated DSBs enzyme inhibitors tested as potential therapeutic agents for anti-cancer therapy are reported.
Insights
DNA double-strand breaks (DSBs) are harmful lesions. Understanding the DNA damage response (DDR), including repair mechanisms and BRCA1
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- DNA double-strand breaks (DSBs) represent a critical type of DNA damage.
- Failure in the DNA damage response (DDR) can lead to cancer development.
- Targeting DDR proteins offers a strategy for selective cancer cell eradication.
Purpose of the Study:
- To provide an overview of the cellular response to DSBs.
- To highlight the roles of repair mechanisms, chromatin modifications, and BRCA1 in genome integrity.
- To review DSB enzyme inhibitors as potential anti-cancer therapeutics.
Main Methods:
- Literature review of DNA double-strand break repair pathways.
- Analysis of the role of chromatin in DNA damage response.
- Survey of inhibitors targeting DSB repair enzymes.
Main Results:
- DSBs trigger a complex DDR involving multiple repair pathways.
- BRCA1 plays a crucial role in maintaining genome stability.
- Several DSB enzyme inhibitors are under investigation for cancer therapy.
Conclusions:
- Targeting DSB repair pathways, particularly those involving BRCA1, is a promising avenue for cancer treatment.
- Combination therapies involving DNA repair inhibitors may enhance the efficacy of chemotherapy and radiotherapy.
- Further research into DSB repair mechanisms and inhibitors is essential for developing novel anti-cancer strategies.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Fixing Double-strand Breaks
Fixing Double-strand Breaks
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle

